Lakefront Biotherapeutics SA
172.9 FTELakefront Biotherapeutics reported revenue of €1.10bn for the 2025 financial year (non-consolidated annual accounts filed with the NBB on 05 Jun 2026), with 172.9 full-time equivalents.
By total assets for 2025, Lakefront Biotherapeutics ranks among the 3 largest of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Lakefront Biotherapeutics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +164 % Equity +25 % Total assets -29 % Headcount (avg FTE) -60 %
Accounts of the company itself (not consolidated). Consolidated group accounts are also filed: they are in the full file.
The full file covers 12 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Lakefront Biotherapeutics's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €1.10bn | ||||
| Net result | €316.9m | ||||
| Equity | €3.15bn | ||||
| Cash | €82.3m | ||||
| EBITDA | €735.5m | ||||
| Total assets | €3.34bn |
Filed annual accounts
- Year ended 31 Dec 2025filed on 05 Jun 2026
- Year ended 31 Dec 2024filed on 22 May 2025
- Year ended 31 Dec 2023filed on 20 Jun 2024
- Year ended 31 Dec 2022filed on 12 May 2023
- Year ended 31 Dec 2021filed on 29 Apr 2022
Lakefront Biotherapeutics's financial analysis
- Solvency94.2%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Lakefront Biotherapeutics
12 active director(s) in the register.
and 6 more
Lakefront Biotherapeutics's shareholders and holdings →Lakefront Biotherapeutics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0466.460.429
- VAT number
- BE0466460429
- Peppol
- Registered · 0208:0466460429 · as of 11 Nov 2026
- Legal form
- SA
- Incorporated
- 06 Jul 1999
- Registered office
- 2800 Mechelen
- Size
- Medium · 172.9 FTE
- Latest accounts
- 2025 · filed on 05 Jun 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Lakefront Biotherapeutics (SA) has been based in Mechelen since 1999, active in: research and experimental development on biotechnology. For 2025, it reports revenue of €1.10bn, a net profit of €316.9m and equity of €3.15bn. With 172.9 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at 94.2%, above the median of its sector (60.4%).
Guide: Checking a Belgian supplier invoice: numbers and IBAN →
Companies similar to Lakefront Biotherapeutics
Companies in the same business, of comparable size and area, outside its group.
- argenx Research and experimental development on natural sciences and engineering Ghent · balance sheet €7.01bn
- UCB Biopharma Manufacture of pharmaceutical preparations Anderlecht · balance sheet €7.15bn
- Omega Pharma Innovation & Development Research and experimental development on natural sciences and engineering Ghent · balance sheet €246.6m
- Ablynx Research and experimental development on natural sciences and engineering Ghent · balance sheet €417.3m
- UCB Developed Brands Research and experimental development on natural sciences and engineering Anderlecht · balance sheet €1.07bn
- AgomAb Therapeutics Technical testing and analysis Antwerp · balance sheet €251.3m
- Genzyme Flanders Manufacture of pharmaceutical preparations Geel · balance sheet €1.00bn
- Kaneka Eurogentec Manufacture of pharmaceutical preparations Seraing · balance sheet €115.4m
Frequently asked questions about Lakefront Biotherapeutics
What is the revenue of Lakefront Biotherapeutics?
According to the 2025 annual accounts filed with the NBB, the revenue of Lakefront Biotherapeutics amounts to 1,102,782,320 €.
What is the VAT number of Lakefront Biotherapeutics?
In Belgium, the VAT number is the company number prefixed with BE: BE0466460429 for Lakefront Biotherapeutics, if the company is VAT-registered. Its company number (CBE) is 0466.460.429.
Where is the registered office of Lakefront Biotherapeutics?
According to the CBE register, the registered office of Lakefront Biotherapeutics is in 2800 Mechelen.
What is the equity of Lakefront Biotherapeutics?
At the close of the 2025 financial year, the equity of Lakefront Biotherapeutics amounts to 3,146,406,781 €, a solvency of 94.2% of total assets.
How many people work at Lakefront Biotherapeutics?
172.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Lakefront Biotherapeutics?
The register lists 12 active mandates at Lakefront Biotherapeutics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Lakefront Biotherapeutics within its sector?
By total assets for 2025, Lakefront Biotherapeutics ranks among the 3 largest of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.
The full file of Lakefront Biotherapeutics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →